DMAA
Drugs Made In·NASDAQ
--
--(--)
--
--(--)
DMAA fundamentals
Drugs Made In (DMAA) released its earnings on Nov 18, 2025: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.
Revenue / YoY
--
--
EPS / YoY
--
--
Report date
Nov 18, 2025
EPS
Actual | |
Forecast | |
Surprise | 0.00% |
Revenue
Actual | -- |
Forecast | -- |
Surprise | 0.00% |
Earnings Call
You can ask Aime
What factors drove the changes in Drugs Made In's revenue and profit?What is Drugs Made In's gross profit margin?What is the market's earnings forecast for Drugs Made In next quarter?What is Drugs Made In's latest dividend and current dividend yield?Did Drugs Made In beat or miss consensus estimates last quarter?What guidance did Drugs Made In's management provide for the next earnings period?What is the revenue and EPS growth rate for Drugs Made In year over year?What were the key takeaways from Drugs Made In's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
